Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
NCT ID: NCT01148563
Last Updated: 2024-01-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
136 participants
INTERVENTIONAL
2009-03-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Failure Patient Self-Management Web Portal Pilot Study
NCT01009151
Heart Failure Educational and Follow up Platform
NCT02110433
Tele-HF: Yale Heart Failure Telemonitoring Study
NCT00303212
CHF Management Using Telemedicine
NCT00309764
Cohort of Heart Failure Patients
NCT03422991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
The Standard Care group will continue regular LSU HCSD disease management care for heart failure patients with no additional intervention.
No interventions assigned to this group
Tele-health Monitoring Group
The tele-monitoring intervention group will have the continual standard care from their physician plus the tele-health monitoring. The tele-health monitor will collect the following data: weight, blood pressure, pulse oximetry, pulse rate, \& patient responses to disease-specific questions regarding changes in state of health for 6 months.
Tele-health Monitoring
Daily tele-health monitoring data will be collected from randomized participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tele-health Monitoring
Daily tele-health monitoring data will be collected from randomized participants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 1 + past CHF diagnosis in LSU database, with history of CHF diagnosis extending back for 12 months
* LSU primary care or chronic disease clinic patient for equal or greater than 6 months.
* On CHF medication for equal to or greater than 6 months
* Have had a past echocardiogram
* Mental competency to consent and participate (determined by clinical judgment and chart abstraction)
* Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use)
* Currently-working conventional telephone line at primary residence
* Grounded electrical power supply at primary residence
* Anticipation of remaining in the LSU HCSD patient population for the next year
* Not on home oxygen therapy
* No planned surgery within the next six months
* Living at home (not institutionalized)
* No history of major organ transplant
* No diagnosis of metastatic or inoperable cancer
* Not under treatment for cancer
* Not under treatment for end-stage renal disease or end-stage liver disease
* 1 + emergency department visit or inpatient stay in past 12 months
Exclusion Criteria
* Have a planned surgery within the next 6 months
* Have a history of major organ transplant
* Have a diagnosis of metastatic or inoperable cancer
* Are under treatment for cancer
* Are under treatment for end-stage renal disease or end-stage liver disease
* Have HIV/AIDS
* Have a cognitive condition, such as Alzheimer's or dementia that would make it difficult for you to understand how to use the tele-health device.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lee Arcement, MD
Role: PRINCIPAL_INVESTIGATOR
Louisiana State University Health Care Services Division
Michael Kaiser, MD
Role: STUDY_CHAIR
Louisiana State University Health Care Services Division
Ronald Horswell, PhD
Role: STUDY_CHAIR
Louisiana State University Health Care Services Division
Jay Besse, BS
Role: STUDY_CHAIR
Louisiana State University Health Care Services Divison
Timothy S. Church, MD, MPH, PhD
Role: STUDY_CHAIR
Pennington Biomedical Research Center
Valerie H. Myers, PhD
Role: STUDY_CHAIR
Pennington Biomedical Research Center
Donna H. Ryan, MD
Role: STUDY_CHAIR
Pennington Biomedical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Earl K. Long Medical Center
Baton Rouge, Louisiana, United States
Leonard J. Chabert Medical Center
Houma, Louisiana, United States
University Medical Center
Lafayette, Louisiana, United States
WO Moss Regional Medical Center
Lake Charles, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 29003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.